300347 泰格医药
已收盘 06-05 15:00:00
资讯
新帖
简况
泰格医药：回购价格不超过人民币60.00元/股
证券之星 · 06-04 20:48
泰格医药：回购价格不超过人民币60.00元/股
泰格医药：公司两位实际控制人积极配合中国证监会的相关工作
证券之星 · 06-04 08:54
泰格医药：公司两位实际控制人积极配合中国证监会的相关工作
新华健康丨泰格医药拟2亿元发起设立产业基金 拓展公司投资渠道
经济参考网 · 06-03 20:44
新华健康丨泰格医药拟2亿元发起设立产业基金 拓展公司投资渠道
泰格医药(03347)将于7月31日派发末期股息每10股1.26元
智通财经 · 06-02
泰格医药(03347)将于7月31日派发末期股息每10股1.26元
泰格医药(03347)选举叶小平担任董事长
智通财经 · 06-02
泰格医药(03347)选举叶小平担任董事长
泰格医药（300347）披露第六届董事会第一次会议决议公告，6月2日股价下跌0.63%
证券之星 · 06-02
泰格医药（300347）披露第六届董事会第一次会议决议公告，6月2日股价下跌0.63%
泰格医药(300347.SZ)：拟2亿元参投上海三生医药私募投资基金
智通财经 · 06-02
泰格医药(300347.SZ)：拟2亿元参投上海三生医药私募投资基金
泰格医药董事会换届落地 两名董事曾被立案调查
财中社 · 06-02
泰格医药董事会换届落地 两名董事曾被立案调查
泰格医药获Norges Bank增持82.57万股 每股作价约30.64港元
新浪港股 · 06-01
泰格医药获Norges Bank增持82.57万股 每股作价约30.64港元
Norges Bank增持泰格医药(03347)82.57万股 每股作价约30.64港元
智通财经 · 05-29
Norges Bank增持泰格医药(03347)82.57万股 每股作价约30.64港元
Norges Bank增持泰格医药(03347)53.48万股 每股作价约32港元
智通财经 · 05-27
Norges Bank增持泰格医药(03347)53.48万股 每股作价约32港元
泰格医药(03347)取得金融机构股票回购贷款承诺函
智通财经 · 05-26
泰格医药(03347)取得金融机构股票回购贷款承诺函
股市必读：泰格医药（300347）今年截至5月22日累计跌幅已超20%
证券之星 · 05-25
股市必读：泰格医药（300347）今年截至5月22日累计跌幅已超20%
泰格医药（300347）披露关于回购公司股份方案的议案，5月19日股价下跌1.08%
证券之星 · 05-19
泰格医药（300347）披露关于回购公司股份方案的议案，5月19日股价下跌1.08%
实控人被立案，10亿回购“护盘”失效：泰格医药股价三日跌超9%
新京报 · 05-17
实控人被立案，10亿回购“护盘”失效：泰格医药股价三日跌超9%
Schroders PLC减持泰格医药(03347)57.93万股 每股作价约35.87港元
智通财经 · 05-15
Schroders PLC减持泰格医药(03347)57.93万股 每股作价约35.87港元
泰格医药（300347）披露持股5%以上股东部分股份回购并解除质押公告，5月15日股价下跌2.5%
证券之星 · 05-15
泰格医药（300347）披露持股5%以上股东部分股份回购并解除质押公告，5月15日股价下跌2.5%
一日之内，两名实控人被立案：泰格医药与迪安诊断背后的合规风暴
新浪证券 · 05-15
一日之内，两名实控人被立案：泰格医药与迪安诊断背后的合规风暴
泰格医药：持股5%以上股东曹晓春解除质押2000.00万股
南方财经网 · 05-14
泰格医药：持股5%以上股东曹晓春解除质押2000.00万股
泰格医药：将数字化和智能化作为核心发展战略
财中社 · 05-14
泰格医药：将数字化和智能化作为核心发展战略
加载更多
公司概况
公司名称：
杭州泰格医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2012-08-17
主营业务：
杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查、培训等服务、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像、实验室。
发行价格：
37.88
{"stockData":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":38.92,"timestamp":1780643010000,"preClose":39.58,"halted":0,"volume":18558643,"delay":0,"changeRate":-0.0167,"floatShares":566000000,"shares":861000000,"eps":0.896,"marketStatus":"已收盘","change":-0.66,"latestTime":"06-05 15:00:00","open":39.86,"high":40.69,"low":38.73,"amount":732000000,"amplitude":0.0495,"askPrice":38.93,"askSize":36,"bidPrice":38.92,"bidSize":51,"shortable":0,"etf":0,"ttmEps":0.896,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":5,"adr":0,"adjPreClose":39.58,"symbolType":"stock","openAndCloseTimeList":[[1780623000000,1780630200000],[1780635600000,1780642800000]],"highLimit":43.54,"lowLimit":35.62,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":861026050,"isCdr":false,"pbRate":1.63,"roa":"--","peRate":43.4375,"roe":"0.23%","epsLYR":1.04,"committee":0.594037,"marketValue":33511000000,"turnoverRate":0.0328,"status":1,"hkstockBrief":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":31.7,"timestamp":1780646952007,"preClose":31.92,"halted":0,"volume":1955310,"delay":0,"premium":"-29.40"},"floatMarketCap":22047000000},"requestUrl":"/m/hq/s/300347/","defaultTab":"news","newsList":[{"id":"2640150586","title":"泰格医药：回购价格不超过人民币60.00元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640150586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640150586?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:48","pubTimestamp":1780577303,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：明天6月2日，你们打算怎样回购泰格医药回复：投资者您好， 公司于2026年5月14日披露《关于回购公司股份方案的公告》，回购价格不超过人民币60.00元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400039293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","UCmain","LU1820825898.SGD","300347","BK0077","BK0216","CYB","CNHmain","MCNHmain","LU1146622755.USD","03347","BK0028","BK0174","BK1141","BK1583","MUCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640133886","title":"泰格医药：公司两位实际控制人积极配合中国证监会的相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2640133886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640133886?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:54","pubTimestamp":1780534455,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药(300347)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好请问公司现在是否在配合调查，请问调查预计什么时候会有清晰结果？泰格医药回复：投资者您好，公司两位实际控制人积极配合中国证监会的相关工作，公司亦持续关注调查的进展情况，并将严格按照监管要求履行信息披露义务。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400004964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","03347","BK1583","300347","BK1576","LU1146622755.USD","BK1141","LU1820825898.SGD","BK0077","BK0174","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640025349","title":"新华健康丨泰格医药拟2亿元发起设立产业基金 拓展公司投资渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=2640025349","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640025349?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:44","pubTimestamp":1780490650,"startTime":"0","endTime":"0","summary":"6月3日，国内CRO龙头企业泰格医药（300347.SZ）发布公告称，公司拟通过全资控股的专业投资平台杭州泰格股权投资合伙企业（有限合伙）（简称“泰格股权投资”），使用自有资金认缴出资2亿元，参与上海三生医药私募投资基金合伙企业（有限合伙）（简称“三生医药基金”）的设立工作。本次投资已经过公司第六届董事会第一次会议审议通过，不构成关联交易及重大资产重组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033759233176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0077","BK1583","BK1576","BK0028","BK0174","BK1141","LU1146622755.USD","300347","LU1820825898.SGD","03347","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640394155","title":"泰格医药(03347)将于7月31日派发末期股息每10股1.26元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640394155","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640394155?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:49","pubTimestamp":1780411775,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，将于2026年7月31日派发截至2025年12月31日止年度的末期股息每10股1.26元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","03347","BK1141","BK1576","BK0216","BK4588","BK0028","BK4585","LU1146622755.USD","LU1820825898.SGD","BK0077","VIG","BK0174","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941333","title":"泰格医药(03347)选举叶小平担任董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941333","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640941333?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:47","pubTimestamp":1780411667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药 发布公告，董事会已审议通过选举叶小平博士担任第六届董事会董事长。其任期自董事会审议通过之日起至第六届董事会任期届满之日止。董事会已审议通过委任闻增玉先生为本公司总经理、吴灏先生为本公司联席总裁、彭沂非先生为本公司首席运营官及杨成成女士为本公司首席财务官，董事会已审议通过将本公司的法定代表人由曹晓春女士变更为闻增玉先生。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK0077","300347","BK1141","LU1146622755.USD","BK0174","LU1820825898.SGD","03347","BK1583","BK0028","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640949253","title":"泰格医药（300347）披露第六届董事会第一次会议决议公告，6月2日股价下跌0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640949253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640949253?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:23","pubTimestamp":1780410205,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，泰格医药报收于39.19元，较前一交易日下跌0.63%，最新总市值为337.44亿元。该股当日开盘39.7元，最高40.08元，最低38.92元，成交额达5.08亿元，换手率为2.28%。近日，泰格医药发布第六届董事会第一次会议决议公告。法定代表人由曹晓春变更为闻增玉。叶小平、曹晓春仍为实际控制人，目前正被中国证监会立案调查，尚未有结论。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1583","BK0028","BK1576","BK0077","LU1820825898.SGD","BK0174","BK1141","300347","LU1146622755.USD","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917470","title":"泰格医药(300347.SZ)：拟2亿元参投上海三生医药私募投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917470","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640917470?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:05","pubTimestamp":1780398322,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(300347.SZ)发布公告，公司拟通过杭州泰格股权投资合伙企业(有限合伙)(简称“投资主体”)参与投资上海三生医药私募投资基金合伙企业(有限合伙)(简称“合伙企业”或“基金”)。合伙企业首期拟认缴出资总额为9.5亿元，投资主体将作为该合伙企业的有限合伙人(LP)以其自有资金认缴出资2亿元。合伙企业投资方向聚焦于创新药物及高端制剂、高端医疗器械、生物技术、高端制药装备等领域。公司此次发起设立产业基金，可以结合公司在生物健康领域的专业优势，拓展公司投资渠道，获取投资收益。同时该合作模式也将帮助公司提升综合服务能力，发展优质项目储备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","300347","159938","BK0174","BK1141","09939","BK1576","BK1574","BK0216","LU1146622755.USD","LU1820825898.SGD","BK1515","BK1161","03347","BK1583","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640176689","title":"泰格医药董事会换届落地 两名董事曾被立案调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2640176689","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640176689?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:53","pubTimestamp":1780397580,"startTime":"0","endTime":"0","summary":"6月2日，泰格医药（300347/03347）发布公告，公司召开2025年度股东会，审议通过了董事会换届选举的相关议案，选举产生了第六届董事会，3名执行董事包括叶小平（董事长）、曹晓春、闻增玉，3名独立非执行董事刘毓文、袁华刚、萧耀熙和1名职工代表董事吴灏。新一届董事会的任期自股东会审议通过之日起为三年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606023757684169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1583","300347","LU1146622755.USD","03347","BK0077","BK0174","BK0028","BK0216","BK1576","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989989","title":"泰格医药获Norges Bank增持82.57万股 每股作价约30.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989989","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640989989?lang=zh_cn&edition=full","pubTime":"2026-06-01 07:29","pubTimestamp":1780270140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，5月28日，Norges Bank增持泰格医药（03347）82.57万股，每股作价30.6386港元，总金额约为2529.83万港元。增持后最新持股数目约为921.57万股，最新持股比例为7.48%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-06-01/doc-inhzwckt8531709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","BK1576","BK0077","BK0028","300347","03347","EWH","BK1583","LU1820825898.SGD","LU1146622755.USD","BK0174","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639627524","title":"Norges Bank增持泰格医药(03347)82.57万股 每股作价约30.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627524","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639627524?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:15","pubTimestamp":1780056943,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月28日，Norges Bank增持泰格医药(03347)82.57万股，每股作价30.6386港元，总金额约为2529.83万港元。增持后最新持股数目约为921.57万股，最新持股比例为7.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","03347","BK1141","BK1576","BK0216","BK0028","LU1146622755.USD","LU1820825898.SGD","BK0077","EWH","BK0174","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638504273","title":"Norges Bank增持泰格医药(03347)53.48万股 每股作价约32港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638504273","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638504273?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:05","pubTimestamp":1779879936,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月22日，Norges Bank增持泰格医药(03347)53.48万股，每股作价32.0015港元，总金额约为1711.44万港元。增持后最新持股数目约为774.89万股，最新持股比例为6.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1576","BK0028","BK0174","03347","LU1820825898.SGD","300347","BK1141","LU1146622755.USD","EWH","BK0077","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638592874","title":"泰格医药(03347)取得金融机构股票回购贷款承诺函","url":"https://stock-news.laohu8.com/highlight/detail?id=2638592874","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638592874?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:32","pubTimestamp":1779784331,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药 发布公告，杭州泰格医药科技股份有限公司于2026年5月13日召开的第五届董事会第二十五次会议审议通过了《关于回购公司股份方案的议案》。本次回购股份实施期限为自股东会审议通过回购股份方案之日起12个月内。公司实际贷款金额合计不超过本次回购方案金额的上限，具体贷款事宜以双方签订的借款合同为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK4211","LU1820825898.SGD","BK0174","LU1146622755.USD","BK0077","FISI","BK1583","BK1141","BK0028","03347","BK0216","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638204301","title":"股市必读：泰格医药（300347）今年截至5月22日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638204301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638204301?lang=zh_cn&edition=full","pubTime":"2026-05-25 01:26","pubTimestamp":1779643572,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，泰格医药报收于42.32元，下跌6.93%，换手率5.54%，成交量31.41万手，成交额13.5亿元。当日关注点来自交易信息汇总：泰格医药5月22日收盘跌6.93%，主力资金当日净流出2505.05万元，前10个交易日累计净流出达1.02亿元，股价同步走低。交易信息汇总股价提醒5月22日泰格医药收盘报42.32元，跌6.93%，当日成交3140.85万元。该股当年累计跌幅21.56%。近90天内共有12家机构对其发布评级，其中买入评级9家，增持评级3家，机构目标均价为76.5元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500000607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK1583","BK0174","BK1576","LU1146622755.USD","BK0028","03347","LU1820825898.SGD","BK0216","BK1141","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636785237","title":"泰格医药（300347）披露关于回购公司股份方案的议案，5月19日股价下跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636785237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636785237?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:08","pubTimestamp":1779199700,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，泰格医药报收于45.61元，较前一交易日下跌1.08%，最新总市值为392.71亿元。近日，杭州泰格医药科技股份有限公司发布《关于召开2026年第二次临时股东会、2026年第二次A股类别股东会议及2026年第二次H股类别股东会议的公告》。会议主要审议《关于回购公司股份方案的议案》及其子议案，包括回购目的、方式、种类、数量、资金总额、价格、期限及授权事项等内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900043179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","LU1820825898.SGD","BK0174","LU1146622755.USD","BK0077","BK1583","BK1141","BK0028","03347","BK0216","300347"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2636870092","title":"实控人被立案，10亿回购“护盘”失效：泰格医药股价三日跌超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636870092","media":"新京报","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636870092?lang=zh_cn&edition=full","pubTime":"2026-05-17 17:52","pubTimestamp":1779011520,"startTime":"0","endTime":"0","summary":"实控人遭立案调查后，泰格医药火速抛出一份最高10亿元的回购计划。5月13日盘后，公司发布公告，宣布拟斥资不低于5亿元且不超过10亿元回购股份，回购价格不超过60元/股。公司火速“护盘”，但二级市场并不买账。5月15日，泰格医药股价收跌2.5%，报46.76元/股。自披露实际控制人被立案后，公司股价已经连续三日收盘下跌，区间跌幅超过9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605173739740329.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605173739740329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","300347","03347","BK0174","BK0077","BK0216","BK0028","LU1146622755.USD","BK1583","BK1576","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635082355","title":"Schroders PLC减持泰格医药(03347)57.93万股 每股作价约35.87港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635082355","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635082355?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:35","pubTimestamp":1778848524,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月14日，Schroders PLC减持泰格医药(03347)57.93万股，每股作价35.8726港元，总金额约为2078.1万港元。减持后最新持股数目为719.4万股，最新持股比例为5.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1583","300347","LU1146622755.USD","03347","BK0077","BK0174","BK0028","BK0216","BK1576","EWH","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088321","title":"泰格医药（300347）披露持股5%以上股东部分股份回购并解除质押公告，5月15日股价下跌2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635088321?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:56","pubTimestamp":1778838975,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，泰格医药报收于46.76元，较前一交易日下跌2.5%，最新总市值为402.62亿元。杭州泰格医药科技股份有限公司于2026年5月14日发布公告，持股5%以上股东曹晓春女士于2026年5月13日办理了部分股份回购并解除质押业务，解除质押股份数量为20,000,000股，占其所持股份比例38.98%，占公司总股本比例2.32%，质权人为财通证券资产管理有限公司。公司控股股东及其一致行动人合计持有公司股份228,553,715股，占公司总股本26.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500034636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0028","LU1820825898.SGD","300347","BK0174","03347","BK1583","BK1141","BK1576","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635702149","title":"一日之内，两名实控人被立案：泰格医药与迪安诊断背后的合规风暴","url":"https://stock-news.laohu8.com/highlight/detail?id=2635702149","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635702149?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:54","pubTimestamp":1778835240,"startTime":"0","endTime":"0","summary":" 近日，A股市场罕见上演“同一人、两家公司、同步被查”的剧情。迪安诊断与泰格医药相继公告，公司董事或实控人因涉嫌持股变动信息披露违法违规，被中国证监会立案调查。其中，泰格医药实际控制人叶小平、曹晓春双双被查，市值422亿的CRO龙头瞬间站上风口浪尖。但无论结果如何，泰格医药与迪安诊断的这一纸公告，已经为A股市场敲响警钟：在法治与敬畏市场的前提下，合规从来不是发展的绊脚石，而是企业唯一真实的护城河。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-05-15/doc-inhxyimm3411499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0174","03347","300347","BK0216","BK0077","BK0197","LU1146622755.USD","LU1820825898.SGD","BK1141","BK0028","BK1583","BK0070","300244","BK0186","BK0042","BK0146","BK0236","BK1576","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635479092","title":"泰格医药：持股5%以上股东曹晓春解除质押2000.00万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635479092","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635479092?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:12","pubTimestamp":1778749920,"startTime":"0","endTime":"0","summary":"南财智讯5月14日电，泰格医药公告，公司持股5%以上股东曹晓春女士近日办理部分股份回购并解除质押业务，本次解除质押股份数量为2000.00万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605143737505788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1146622755.USD","BK0216","BK1576","03347","BK0174","LU1820825898.SGD","300347","BK1583","BK0028","BK1141","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635914007","title":"泰格医药：将数字化和智能化作为核心发展战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2635914007","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635914007?lang=zh_cn&edition=full","pubTime":"2026-05-14 15:52","pubTimestamp":1778745120,"startTime":"0","endTime":"0","summary":"5月14日，泰格医药（300347/03347）发布公告，公司于2026年5月13日召开了业绩说明会。公司表示，将数字化、智能化作为核心发展战略，由智能研究院统筹推进，全年稳步落地各项工作，力求实现技术与业务深度融合。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605143737376525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0174","300347","LU1146622755.USD","LU1820825898.SGD","BK1141","BK1583","BK0028","BK0077","BK0216","BK1576","03347"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780687153128,"stockEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.279},{"period":"3month","weight":-0.3216},{"period":"6month","weight":-0.2129},{"period":"1year","weight":-0.2415},{"period":"ytd","weight":-0.3136}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0234},{"period":"6month","weight":0.032},{"period":"1year","weight":0.1902},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州泰格医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2012-08-17","address":"浙江省杭州市滨江区浦沿街道陆家潭街508号6层601-610室","registeredCapital":"86102万元","survey":" 杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查、培训等服务、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像、实验室。","listedPrice":37.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,300347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}